Alcon AG | ALC - Capital Ordinaire





Capital Ordinaire Changement Date
AstraZeneca USD 1.55B 73K 2026-03
Bayer EUR 982.42M 0 2025-12
Essilor EUR 463.05M 1.9M 2025-12
Fresenius EUR 563.24M 0 2025-12
Fresenius Medical Care EUR 270.09M 9.2M 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
GRIFOLS EUR 680.58M 0 2026-03
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2026-03
Novartis USD 1.91B 60K 2026-03
Philips EUR 952.02M 729K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Smith & Nephew USD 875.96M 1.61M 2025-12
Sonova Holding CHF 59.61M 10.56K 2025-06
UCB EUR 190.36M 365.15K 2025-12